The global Cell culture market is projected to grow from USD 33.07 billion in 2026 to USD 58.42 billion by 2031, at a CAGR of 12.1% during the forecast period. The market was valued at USD 30.23 billion in 2025. The growth of the cell culture market is driven by the rising demand for biologics and biosimilars, expanding vaccine production, increasing adoption of cell and gene therapy and regenerative medicine workflows, and the growing use of cell-based models in drug discovery and toxicity testing.
The market is also supported by increasing R&D investments from pharmaceutical and biotechnology companies and growing government support for biomanufacturing. Technological advancements in serum-free and chemically defined media, single-use bioreactors, closed processing systems, 3D cell culture, organoids, and automated cell culture platforms are further expanding the applications of cell culture technologies across research, drug development, biomanufacturing, and advanced therapies.
Spotlights on the Industry’s Leading Cell Culture Companies
The cell culture industry is evolving from conventional laboratory cultivation toward more standardized, scalable, automated, and application-specific workflows. Companies operating in this market are expanding their portfolios across culture media, reagents, consumables, bioreactors, laboratory equipment, automation solutions, and specialized platforms to support research and commercial biomanufacturing.
1. Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific offers a broad portfolio of cell culture products and solutions supporting academic research, pharmaceutical development, biotechnology, and biomanufacturing applications. Its portfolio spans cell culture media, sera, reagents, plastics, vessels, and related laboratory technologies.
The company supports workflows ranging from basic cell biology and research to large-scale bioprocessing, helping researchers and biopharmaceutical manufacturers address requirements for reproducibility, scalability, and process consistency.
2. Danaher Corporation (US)
Danaher Corporation participates in the cell culture ecosystem through its life sciences and bioprocessing businesses, providing technologies used across cell culture, biomanufacturing, and advanced therapeutic workflows.
Its portfolio supports applications including upstream processing, cell expansion, media preparation, single-use technologies, and process development, enabling biopharmaceutical companies to improve scalability and process control.
3. Sartorius AG (Germany)
Sartorius provides cell culture and bioprocessing technologies designed to support research, process development, and commercial-scale biomanufacturing. Its portfolio includes bioreactors, single-use systems, cell culture media, and process monitoring technologies.
The company’s solutions are used in workflows involving biologics, vaccines, cell and gene therapies, and other advanced biopharmaceutical applications where scalable and controlled cell culture processes are essential.
4. Merck KGaA (Germany)
Merck KGaA offers cell culture media, supplements, reagents, process solutions, and bioprocessing technologies for pharmaceutical and biotechnology applications. Its portfolio addresses both research-scale and manufacturing-oriented cell culture requirements.
The company is also active in technologies supporting the development and production of biologics, helping customers improve cell growth, productivity, process consistency, and manufacturing efficiency.
5. Corning Incorporated (US)
Corning provides a wide range of cell culture consumables and laboratory products used in research, drug discovery, and biotechnology applications. Its portfolio includes cell culture vessels, plates, flasks, surfaces, and specialized products designed for different cell-based workflows.
Corning’s technologies support conventional two-dimensional cell culture as well as more advanced applications involving three-dimensional models and specialized cell culture systems.
6. FUJIFILM Holdings Corporation (Japan)
FUJIFILM Holdings participates in the cell culture market through its life sciences and bioprocessing activities. The company provides technologies and services supporting cell culture, biologics manufacturing, and advanced therapeutic development.
Its capabilities contribute to the growing demand for scalable biomanufacturing solutions as pharmaceutical and biotechnology companies expand production of biologics, vaccines, and next-generation therapies.
7. BD (US)
BD provides cell culture-related products, laboratory technologies, and research tools used across cell biology, life sciences research, and biopharmaceutical workflows. Its solutions support applications involving cell analysis, handling, preparation, and research.
The company’s technologies contribute to integrated workflows in research and clinical laboratories, particularly where reproducibility and efficient cell processing are important.
8. Eppendorf SE (Germany)
Eppendorf offers laboratory equipment and consumables supporting cell culture and cell biology workflows. Its portfolio includes cell culture vessels, laboratory instruments, bioreactors, centrifugation technologies, and related equipment.
The company’s solutions are used by academic institutions, research laboratories, biotechnology companies, and pharmaceutical organizations for controlled and reproducible cell culture processes.
9. Lonza (Switzerland)
Lonza provides cell culture products, services, and manufacturing capabilities supporting pharmaceutical, biotechnology, and advanced therapy applications. Its portfolio covers areas such as cell and gene therapy, biologics, cell expansion, and bioprocess development.
The company’s expertise in cell and bioprocess technologies positions it within workflows that require scalable cell culture systems and specialized solutions for advanced therapeutic manufacturing.
10. Getinge AB (Sweden)
Getinge provides equipment and technologies used in biopharmaceutical and laboratory environments, including solutions supporting controlled processing and biomanufacturing workflows.
Its technologies can contribute to cell culture and upstream processing environments where process control, contamination management, and scalable manufacturing infrastructure are important considerations.
11. Agilent Technologies, Inc. (US)
Agilent Technologies provides analytical instruments, consumables, and laboratory solutions that support cell culture research, biopharmaceutical development, and quality-related workflows.
Its technologies can be integrated into cell-based research and bioprocessing environments to support characterization, analysis, and process monitoring throughout research and development activities.
12. HiMedia Laboratories (India)
HiMedia Laboratories provides culture media, reagents, laboratory consumables, and other products used across life sciences and microbiological research. Its portfolio supports research laboratories, biotechnology applications, and cell culture-related workflows.
The company serves a broad customer base and contributes to the growing availability of laboratory and culture media solutions across emerging and established research markets.
13. Miltenyi Biotec (Germany)
Miltenyi Biotec specializes in technologies for cell biology and cell processing, with solutions supporting cell isolation, cell culture, cell analysis, and cell therapy research.
Its technologies are particularly relevant to advanced cell-based workflows where researchers require efficient cell separation, expansion, characterization, and processing for research and therapeutic applications.
14. STEMCELL Technologies (Canada)
STEMCELL Technologies provides specialized cell culture media, reagents, supplements, and research tools for stem cell biology, immunology, cancer research, organoid development, and regenerative medicine.
The company’s portfolio supports increasingly sophisticated cell-based research models, including stem cell expansion, differentiation, 3D culture, and organoid-based applications.
15. Solida Biotech GmbH (Germany)
Solida Biotech provides bioprocessing technologies and equipment supporting laboratory and industrial biotechnology applications. Its solutions are relevant to controlled cultivation and bioprocess development where scalability and process management are important.
The company’s technologies contribute to the broader ecosystem of equipment and systems required for developing and scaling cell-based and biotechnology processes.
Conclusion:
The cell culture market expanding as pharmaceutical and biotechnology companies increase investments in biologics, vaccines, cell and gene therapies, regenerative medicine, and cell-based drug discovery. At the same time, innovations in serum-free and chemically defined media, single-use bioreactors, 3D cell culture, organoids, closed processing, and automation are transforming traditional cell culture workflows.
